Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-26-114567
Filing Date
2026-03-18
Accepted
2026-03-18 18:43:51
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3325
2 EX-24 ck0001944885-ex24.htm EX-24 14895
  Complete submission text file 0001193125-26-114567.txt   19711
Mailing Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404 1-650-209-4055
Apollomics Inc. (Issuer) CIK: 0001944885 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 F., NO. 5, ALY. 59, LN. 38, DANJIN RD. TAMSUI DISTRICT NEW TAIPEI CITY Taiwan, Province of China 251035
Business Address
TSAI HSIEN-SHU (Reporting) CIK: 0002115218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41670 | Film No.: 26771288